Chuang Hao-Yuan 4

What Happened
CFO Chuang Hao‑Yuan sold a total of 6,200 American depositary shares (ADSs) of Belite Bio in multiple open‑market transactions on April 9, 2026, realizing roughly $1,125,304. The breakdown: 2,000 shares at $180.35 ($360,695); 2,000 shares at $181.40 ($362,790); 1,909 shares at $182.58 ($348,542); and 291 shares at $183.08 ($53,277). Each ADS represents one ordinary share of the issuer.

Key Details

• Transaction date reported: 2026-04-09; Form 4 filed: 2026-04-13 (Accession 0001193125-26-152883).
• Sales: total 6,200 ADSs for approximately $1,125,304 in proceeds.
• Prices: sales ranged roughly $180.00–$183.21 (footnotes show weighted averages for sub‑ranges).
• Plan: Sales were made pursuant to a Rule 10b5‑1 trading plan adopted 12/22/2025 (footnote F2).
• Post‑transaction holdings: not provided in the excerpt of data supplied.
• Footnotes F3–F6 note that reported prices are weighted averages across price ranges and that the filer will provide per‑price quantities upon request.

Context
These were outright sales (Disposition code "S") under a pre‑arranged 10b5‑1 plan, which typically documents scheduled trades made regardless of contemporaneous company developments. Sales are neutral factual events and do not by themselves indicate management sentiment; purchases are usually more informative about insider bullishness.